Sponsored Links


Other Topics
Sponsored Links



Quote of the Day

"Nothing will work unless you do."

Maya Angelou

FEATURED
HEALTH
PRODUCTS
 
Guide To Healthier Eating And Weight
 
The Ultimate Collection Of Health Ebooks
 
A Healthy Back In Ten Minutes A Day
 
Complete Guide To Healthy Eating
 
Natural Health Remedies To Help Stress
 




 


Google


Warning: fopen(stopka/index.php) [function.fopen]: failed to open stream: No such file or directory in /stopka.php on line 117

Warning: fopen(stopka/6655d922aa2c1bbb44b556c10262be35.txt) [function.fopen]: failed to open stream: No such file or directory in /stopka.php on line 117


 
Featured Breast Cancer Articles

Cancer- The Real Facts
Cancer has a fearsome reputation. Not without reason either. It is a disease that has not yet fully yielded to the skills and intelligence of medical scientists and doctors. And, as if the pain from the disease is not enough, the treatment for cancer, ...

Coffee and Tea Are Good for Us? Yes! (First in a Series)
You'll be pleased to learn that many of the foods and drinks you love are not just "okay" as an occasional indulgence-they're good for you! Let's begin with coffee and tea.and I invite you to read my related articles on wine and beer, and on chocolate. ...

The Facts About Breast Implant Surgery
From a very early age, women are subjected to ideals regarding the size and shape of their breasts. Modern media - glossy magazines and movies - tell us how big and what shape they should be. Many women consider and eventually have breast implants in ...





Are Obese Women Getting Short-Changed By Chemotherapy Treatments?
 
How much chemotherapy does an obese woman need? Typically an obese woman with breast cancer would receive reduced doses of chemotherapy as they battle breast cancer. Back in June of 2005, a study published in the Archives of Internal Medicine concluded that obese women should receive chemotherapy based on actual women, and not in reduced amounts as the standard practice.

And now again a study presented in the August 2005 edition of Lancet claims that doctors should not reduce chemotherapy doses for obese women when no receptors for the hormone oestrogen have been found on the breast cancer cells. This type of cancer is called oestrogen-receptor negative.

Clinicians often reduce chemotherapy doses for obese patients because of worries about how the treatment may react with the patient and affect their overall health.

According to the study's director Marco Colleoni of the European Institute of Oncology, Italy, and his colleagues, reducing the first course of chemotherapy for obese patients with oestrogen-receptor negative breast cancer proves "detrimental".

Colleoni and his team looked at the relation between body-mass index (BMI), chemotherapy dose reduction, oestrogen receptor expression, and outcome for pre-menopausal women with breast cancer by examining data from four randomized trials.

They found that 97 out of 249 obese patients received less than 85% of protocol specified dose during the first course of chemotherapy compared with patients with normal and intermediate BMI.

Obese patients with oestrogen-receptor negative disease that received 85% or more of the first protocol specified dose had significantly better disease-free survival and overall survival than those who received less than 85% of the normally recommended dosage.

Yet, obese patients with oestrogen-receptor positive breast cancer who had reduced doses of chemotherapy did not have a significant difference in their outcome compared with those given the recommended chemotherapy doses.

And contrary to popular practice, the researchers also noticed that obese patients initially treated with protocol doses of chemotherapy did not have more toxicity than patients who received reduced doses.

Dr Marco Colleoni concluded that, "Our findings suggest that for women with ER-absent or ER-low tumours, reduction in chemotherapy dose should be avoided."

The message for obese women coping with cancer is to be aware of your risks and rights. Ask your doctor will she recommend lower doses of chemotherapy for you based on your weight and ask why.

Resource: Lancet, Archives of Internal Medicine
About the Author
Health author and Stanford University graduate Naweko San-Joyz lovingly writes from her home in San Diego. Her works include Acne Messages: Crack the Code of Your Zits and Say Goodbye to Acne (ISBN: 0974912204) and Skinny Fat Chicks, Why We're Still Not Getting This Dieting Thing (ISBN: 0974912212). http://www.Noixia.com>http://www.Noixia.com

Breast Cancer News



ABC News

Want to lower breast cancer risk? Lose a little weight
Los Angeles Times
For postmenopausal women who are obese, breast cancer is more likely. That's because fat tissue seems to behave essentially as an organ of the endocrine system, pumping out the hormone estrogen. And estrogen is a driver of many common breast cancers.
Small weight loss effectively reduces sex hormones linked with breast cancerFox News
Moderate Weight Loss Can Decrease Breast Cancer RiskABC News
Dieting May Lower Hormone Levels Tied to Breast CancerPhiladelphia Inquirer
TIME -Times of India
all 40 news articles »

Galena Biopharma's Breast Cancer Vaccine Sprouts More Red Flags
TheStreet.com
By Adam Feuerstein 05/22/12 - 02:23 PM EDT LAKE OSWEGO, Oregon (TheStreet) -- More red flags have been found staked into Galena Biopharma's(GALE) breast cancer vaccine NeuVax. Updated, 60-month follow-up results from a Neuvax phase II study scheduled ...
Galena Biopharma With Near Term ASCO CatalystSeeking Alpha

all 2 news articles »

Plenty of options after breast cancer surgery
MiamiHerald.com
And is there anything that can be done for the other breast so that they can be similar in clothes or a bathing suit? Congratulations on being a breast cancer survivor! Breast cancer affects one in approximately eight women in America and because of ...

and more »

Tesetaxel Results as Initial Chemotherapy for Women With Recurrent Breast ...
MarketWatch (press release)
BERKELEY HEIGHTS, NJ, May 22, 2012 (GLOBE NEWSWIRE) -- Genta Incorporated (GNTA) today announced results from the Company's Phase 2 clinical trial using tesetaxel as initial, single-agent chemotherapy in women with advanced breast cancer.
Advanced breast cancer drug produces positive phase 2 resultsMedCity News
Shares of Genta Inc. (GNTA) Climb as Company announces Phase II ResultsTech24

all 7 news articles »

Roche Drugs To Be Key Focus At Upcoming US Cancer Meeting ASCO
Wall Street Journal
VX) newest breast cancer drug is expected to be displayed in the US next month at a high-profile medical meeting. Roche is planning to present additional data from key studies at the American Society of Clinical Oncology, or ASCO, annual meeting in ...

and more »